| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active SMS-based influenza vaccine safety surveillance in Australian children
|
Pillsbury, Alexis
|
|
2017
|
35 |
51 |
p. 7101-7106
|
artikel
|
| 2 |
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen
|
Kalimuddin, Shirin
|
|
2017
|
35 |
51 |
p. 7127-7132
|
artikel
|
| 3 |
CAPiTA: The urine antigen detection (SSUAD) was not validated for PCV13 vaccinated patients
|
Van Renterghem, Dirk Marc
|
|
2017
|
35 |
51 |
p. 7077
|
artikel
|
| 4 |
Construction of a novel vaccine by conjugating a B-cell epitope of DPP4 to peptide IA2(5)-P2-1 to significantly control type 1 diabetes in NOD mice
|
Li, Ya
|
|
2017
|
35 |
51 |
p. 7187-7197
|
artikel
|
| 5 |
Controlled human infections
|
Roestenberg, Meta
|
|
2017
|
35 |
51 |
p. 7070-7076
|
artikel
|
| 6 |
Determinants of influenza vaccination among high-risk Black and White adults
|
Crouse Quinn, Sandra
|
|
2017
|
35 |
51 |
p. 7154-7159
|
artikel
|
| 7 |
Development of a synthetic Vi polysaccharide vaccine for typhoid fever
|
Ni, Yawei
|
|
2017
|
35 |
51 |
p. 7121-7126
|
artikel
|
| 8 |
Editorial Board/Aims and Scope
|
|
|
2017
|
35 |
51 |
p. IFC
|
artikel
|
| 9 |
Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
|
Webber, Chris
|
|
2017
|
35 |
51 |
p. 7078
|
artikel
|
| 10 |
Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands
|
van Deursen, A.M.M.
|
|
2017
|
35 |
51 |
p. 7107-7113
|
artikel
|
| 11 |
Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview
|
Pan, Yang
|
|
2017
|
35 |
51 |
p. 7133-7138
|
artikel
|
| 12 |
Long-term humoral immunity induced by CVC1302-adjuvanted serotype O foot-and-mouth disease inactivated vaccine correlates with promoted T follicular helper cells and thus germinal center responses in mice
|
Du, Luping
|
|
2017
|
35 |
51 |
p. 7088-7094
|
artikel
|
| 13 |
Measuring the timeliness of childhood vaccinations: Using cohort data and routine health records to evaluate quality of immunisation services
|
Walton, Suzanne
|
|
2017
|
35 |
51 |
p. 7166-7173
|
artikel
|
| 14 |
No conflicting results in the article “HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway”
|
Feiring, Berit
|
|
2017
|
35 |
51 |
p. 7082-7083
|
artikel
|
| 15 |
Non-specific effects of childhood vaccinations – A case control study nested into a Health and Demographic Surveillance System in rural Burkina Faso
|
Pfeiffer, G.
|
|
2017
|
35 |
51 |
p. 7114-7120
|
artikel
|
| 16 |
Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection
|
Gomi, Rika
|
|
2017
|
35 |
51 |
p. 7174-7180
|
artikel
|
| 17 |
Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality
|
Burnett, Eleanor
|
|
2017
|
35 |
51 |
p. 7198-7203
|
artikel
|
| 18 |
Prevalence and factors associated with influenza vaccination of persons over 65 years old in Spain (2009–2014)
|
Dios-Guerra, Caridad
|
|
2017
|
35 |
51 |
p. 7095-7100
|
artikel
|
| 19 |
Q-Vax Q fever vaccine failures, Victoria, Australia 1994–2013
|
Bond, Katherine A.
|
|
2017
|
35 |
51 |
p. 7084-7087
|
artikel
|
| 20 |
Response to Curran and Mrkvan, Letter to the Editor: Response to publication by Hoshi SL et al.: Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan
|
Hoshi, Shu-ling
|
|
2017
|
35 |
51 |
p. 7080
|
artikel
|
| 21 |
Response to publication by Hoshi SL et al.: Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan
|
Curran, Desmond
|
|
2017
|
35 |
51 |
p. 7079
|
artikel
|
| 22 |
RETRACTED: Conflicting results in article describing “HPV-vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis”
|
Andersson, L.
|
|
2017
|
35 |
51 |
p. 7081
|
artikel
|
| 23 |
Safety and immunogenicity of a novel multiple antigen pneumococcal vaccine in adults: A Phase 1 randomised clinical trial
|
Entwisle, Claire
|
|
2017
|
35 |
51 |
p. 7181-7186
|
artikel
|
| 24 |
Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007–2012) circulating in Southeast Asia, East Asia and Far East
|
Mahapatra, Mana
|
|
2017
|
35 |
51 |
p. 7147-7153
|
artikel
|
| 25 |
The frontline of controlled human malaria infections: A report from the controlled human infection models Workshop in Leiden University Medical Centre 5 May 2016
|
Roestenberg, Meta
|
|
2017
|
35 |
51 |
p. 7065-7069
|
artikel
|
| 26 |
Th1 epitope peptides induce protective immunity against Rickettsia rickettsii infection in C3H/HeN mice
|
Wang, Pengcheng
|
|
2017
|
35 |
51 |
p. 7204-7212
|
artikel
|
| 27 |
Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice
|
Wagner, Leslie D.
|
|
2017
|
35 |
51 |
p. 7160-7165
|
artikel
|
| 28 |
Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity
|
Garg, R.
|
|
2017
|
35 |
51 |
p. 7139-7146
|
artikel
|
Tijdschrift beschrijving